pipette
ESEspañol

Antithrombotic Therapy After Left Atrial Appendage Occlusion

Vivek Yerrapu Reddy, Walid I. Saliba, Thomas E. Waggoner, Devi G. Nair, Stanislav Weiner, Rudolph F. Evonich, Michael H. Hoskins, Andrew Dublin, Michael J. Rinaldi, Gaurang D. Gandhi, Jonathan Walter Dukes, Madhu Reddy, David B. DeLurgio, Venkat R. Iyer, Ganesh Venkataraman, Ashish Sadhu, Vamsee Yaganti, Kevin M. Trulock, Douglas N Gibson, Mohamad Adnan Alkhouli, Manish H. Shah, Shephal K. Doshi, Andrea Natale, Megan J. Coylewright, C. Michael Gibson, Ahmed A. Kolkailah, Wael A. Jaber, Krystal Leger, Elizabeth Matznick, Thomas Christen, Brad S Sutton, Kenneth M. Steín, Saibal Kar

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Conclusions and Relevance Both reduced-dose NOACs and aspirin alone were noninferior to DAPT for 6-month outcomes after uncomplicated LAAC.
Limitation the authors admit
Bleeding and 45-day device-related thrombus rates were exploratory without multiplicity adjustment.

Appeared: Wednesday, November 4. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.21361